Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice

Dysregulated glucagon drives hyperfunction in hepatic glucose output, which is the main cause of persistent hyperglycemia in type 2 diabetes. Berberine (Zhang et al., 2010) has been used as a hypoglycemic agent, yet the mechanism by which BBR inhibits hepatic gluconeogenesis remains incompletely und...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ying, Jin, Jing, Liu, Peiyu, Song, Yu, Zhang, Hui, Sheng, Liang, Zhou, Huifang, Jiang, Bijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961611/
https://www.ncbi.nlm.nih.gov/pubmed/31976031
http://dx.doi.org/10.1155/2020/6210526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961611/
https://www.ncbi.nlm.nih.gov/pubmed/31976031
http://dx.doi.org/10.1155/2020/6210526

Ejemplares similares